Risk of Pancreatitis Following Treatment of Irritable Bowel Syndrome With Eluxadoline
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 16 (3) , 378-384.e2
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Eluxadoline Benefits Patients With Irritable Bowel Syndrome With Diarrhea in a Phase 2 StudyGastroenterology, 2013
- Lomotil (Diphenoxylate) Dependence in IndiaIndian Journal of Psychological Medicine, 2013
- Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho‐education group interventionAlimentary Pharmacology & Therapeutics, 2012
- Irritable bowel syndrome – DiarrhoeaBest Practice & Research Clinical Gastroenterology, 2012
- Sudden Severe Abdominal Pain After a Single Low Dose of Paracetamol/Codein in a Cholecystectomized Patient: Learning From a Case ReportAmerican Journal of Therapeutics, 2010
- Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome – A randomized controlled trialBehaviour Research and Therapy, 2010
- International Survey of Patients With IBSJournal of Clinical Gastroenterology, 2009
- Biliary motilityDigestive Diseases and Sciences, 1994
- DIPHENOXYLATE AND PANCREATITISThe Lancet, 1985
- Long-Term Survey of the Treatment of Diarrhoea with LoperamideDigestion, 1977